Mostrar el registro sencillo del ítem

dc.contributor.author
Lucero, Diego Martín  
dc.contributor.author
Zago, Valeria  
dc.contributor.author
López, Gustavo  
dc.contributor.author
Cacciagiú, Leonardo D.  
dc.contributor.author
Lopez, Graciela Ines  
dc.contributor.author
Wigdorovitz de Wikinski, Regina Luisa  
dc.contributor.author
Nakajima, Katsuyuki  
dc.contributor.author
Schreier, Laura Ester  
dc.date.available
2019-01-03T14:33:50Z  
dc.date.issued
2012-03  
dc.identifier.citation
Lucero, Diego Martín; Zago, Valeria; López, Gustavo; Cacciagiú, Leonardo D.; Lopez, Graciela Ines; et al.; Predominance of large VLDL particles in metabolic syndrome, detected by size exclusion liquid chromatography; Pergamon-Elsevier Science Ltd; Clinical Biochemistry; 45; 4-5; 3-2012; 293-297  
dc.identifier.issn
0009-9120  
dc.identifier.uri
http://hdl.handle.net/11336/67279  
dc.description.abstract
Objective: To study size heterogeneity of triglyceride rich lipoproteins (TRL) in metabolic syndrome (MS). Design and methods: Thirty MS patients and 14 healthy subjects were included. In fasting serum we measured: lipid profile, free fatty acids (FFA) and adiponectin; TRL were isolated (d < 1.006 g/mL) and analysis by size exclusion HPLC followed by UV detection was performed; each subfraction was expressed as percentage of total TRL. Results: MS patients, even those with normal triglycerides, presented higher proportion of very large VLDL (90. nm diameter) and large VLDL (60. nm) and slightly lower of typical VLDL (37 nm) (p < 0.04); increased FFA (p. =0.04) and lower adiponectin (p=0.001). FFA correlated with large VLDL% (r. =0.58; p. =0.003), independently of insulin-resistance and waist. Furthermore, the lower the adiponectin, the greater the predominance of large VLDL (r. = - 0.40; p. =0.04). Conclusion: MS was associated with large VLDL, described as more atherogenic beyond triglyceride levels. Size exclusion HPLC would represent a useful tool for assessing subfractions' lipoprotein profile. © 2012 Elsevier Inc.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Pergamon-Elsevier Science Ltd  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
Adiponectin  
dc.subject
Free Fatty Acids  
dc.subject
Metabolic Syndrome  
dc.subject
Size Exclusion Hplc  
dc.subject
Triglyceride Rich Lipoproteins  
dc.subject
Vldl  
dc.subject.classification
Otras Ciencias de la Salud  
dc.subject.classification
Ciencias de la Salud  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Predominance of large VLDL particles in metabolic syndrome, detected by size exclusion liquid chromatography  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2019-01-02T19:56:31Z  
dc.journal.volume
45  
dc.journal.number
4-5  
dc.journal.pagination
293-297  
dc.journal.pais
Países Bajos  
dc.journal.ciudad
Amsterdam  
dc.description.fil
Fil: Lucero, Diego Martín. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina  
dc.description.fil
Fil: Zago, Valeria. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina  
dc.description.fil
Fil: López, Gustavo. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; Argentina  
dc.description.fil
Fil: Cacciagiú, Leonardo D.. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina  
dc.description.fil
Fil: Lopez, Graciela Ines. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina  
dc.description.fil
Fil: Wigdorovitz de Wikinski, Regina Luisa. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina  
dc.description.fil
Fil: Nakajima, Katsuyuki. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina. Gunma University; Japón  
dc.description.fil
Fil: Schreier, Laura Ester. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina  
dc.journal.title
Clinical Biochemistry  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0009912011027780  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/https://doi.org/10.1016/j.clinbiochem.2011.12.013